Z
Zenas Biopharma Inc
NASDAQ:ZBIO
Zenas Biopharma Inc
NASDAQ:ZBIO
Price:
22.19
USD
5.37%
Market Closed
Market Cap:
$1.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Z
|
Zenas Biopharma Inc
NASDAQ:ZBIO
|
US |
|
Wing Tai Holdings Ltd
SGX:W05
|
SG |
Balance Sheet
Balance Sheet Decomposition
Zenas Biopharma Inc
Zenas Biopharma Inc
Balance Sheet Decomposition is not available for
Zenas Biopharma Inc
Zenas Biopharma Inc
Balance Sheet
Zenas Biopharma Inc
Zenas Biopharma Inc
Currency: USD
| Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
67
|
57
|
320
|
|
| Cash |
67
|
57
|
320
|
|
| Short-Term Investments |
0
|
0
|
31
|
|
| Other Current Assets |
1
|
3
|
5
|
|
| Total Current Assets |
68
|
60
|
356
|
|
| PP&E Net |
2
|
1
|
1
|
|
| Other Long-Term Assets |
4
|
7
|
13
|
|
| Total Assets |
75
N/A
|
68
-9%
|
370
+443%
|
|
| Liabilities | ||||
| Accounts Payable |
6
|
5
|
17
|
|
| Accrued Liabilities |
20
|
17
|
40
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
|
| Total Current Liabilities |
26
|
23
|
57
|
|
| Long-Term Debt |
0
|
20
|
0
|
|
| Other Liabilities |
1
|
0
|
0
|
|
| Total Liabilities |
27
N/A
|
44
+64%
|
58
+31%
|
|
| Equity | ||||
| Common Stock |
240
|
250
|
0
|
|
| Retained Earnings |
193
|
230
|
387
|
|
| Additional Paid In Capital |
1
|
5
|
700
|
|
| Other Equity |
0
|
0
|
0
|
|
| Total Equity |
48
N/A
|
24
-49%
|
312
+1 182%
|
|
| Total Liabilities & Equity |
75
N/A
|
68
-9%
|
370
+443%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
40
|
40
|
42
|
|
Switch to:
Switch to:
See Also
Discover More
